» Articles » PMID: 28478590

Simultaneous Pancreas and Kidney Transplantation-Is It a Treatment Option for Patients With Type 2 Diabetes Mellitus? An Analysis of the International Pancreas Transplant Registry

Overview
Journal Curr Diab Rep
Publisher Current Science
Specialty Endocrinology
Date 2017 May 8
PMID 28478590
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose Of Review: Pancreas transplantation remains the best long-term treatment option to achieve euglycemia and freedom from insulin in patients with labile diabetes mellitus. It is an approved procedure for type 1 (T1DM), but it is still considered controversial for type 2 diabetes mellitus (T2DM).

Recent Findings: This study analyzed all primary deceased donor pancreas transplants in patients with T2DM reported to IPTR/UNOS between 1995 and 2015. Characteristics, outcomes, and risk factors over time were determined using univariate and multivariate methods. The focus was on simultaneous pancreas/kidney (SPK) transplants, the most common pancreas transplant category. Patient, pancreas, and kidney graft survival rates increased significantly over time and reached 95.8, 83.3, and 91.1%, respectively, at 3 years posttransplant for transplants performed between 2009 and 2015. SPK is a safe procedure with excellent pancreas and kidney graft outcome in patients with T2DM. The procedure restores euglycemia and freedom from insulin and dialysis. Based on our results, SPK should be offered to more uremic patients with labile T2DM.

Citing Articles

[Abdominal organ transplantation in multimorbid patients].

Bauschke A, Ali-Deeb A, Dondorf F, Rauchfuss F, Rohland O, Settmacher U Chirurgie (Heidelb). 2024; 96(2):124-129.

PMID: 39643669 DOI: 10.1007/s00104-024-02201-y.


Recent advances associated with cardiometabolic remodeling in diabetes-induced heart failure.

Sharma G, Chaurasia S, Carlson M, Mishra P Am J Physiol Heart Circ Physiol. 2024; 327(6):H1327-H1342.

PMID: 39453429 PMC: 11684949. DOI: 10.1152/ajpheart.00539.2024.


Simultaneous Pancreas-Kidney Transplant Outcomes Stratified by Autoantibodies Status and Pretransplant Fasting C-peptide.

Parajuli S, Tamburrini R, Aziz F, Dodin B, Astor B, Mandelbrot D Transplant Direct. 2024; 10(11):e1721.

PMID: 39399059 PMC: 11469883. DOI: 10.1097/TXD.0000000000001721.


Analysis of Rejection, Infection and Surgical Outcomes in Type I Versus Type II Diabetic Recipients After Simultaneous Pancreas-Kidney Transplantation.

Martinez E, Pham P, Wang J, Stalter L, Welch B, Leverson G Transpl Int. 2024; 37:13087.

PMID: 39364120 PMC: 11446817. DOI: 10.3389/ti.2024.13087.


Video-assisted Retroperitoneal Debridement for Graft Pancreatitis.

Shaw B, Fabricius M, Nauser C, Zani S, Knechtle S Transplant Direct. 2024; 10(8):e1682.

PMID: 39076521 PMC: 11286245. DOI: 10.1097/TXD.0000000000001682.


References
1.
Friedman A, Friedman E . Pancreas transplantation for type 2 diabetes at U.S. Transplant centers. Diabetes Care. 2002; 25(10):1896. DOI: 10.2337/diacare.25.10.1896. View

2.
Kleinclauss F, Fauda M, Sutherland D, Kleinclauss C, Gruessner R, Matas A . Pancreas after living donor kidney transplants in diabetic patients: impact on long-term kidney graft function. Clin Transplant. 2009; 23(4):437-46. DOI: 10.1111/j.1399-0012.2009.00998.x. View

3.
Panunzi S, Carlsson L, De Gaetano A, Peltonen M, Rice T, Sjostrom L . Determinants of Diabetes Remission and Glycemic Control After Bariatric Surgery. Diabetes Care. 2015; 39(1):166-74. DOI: 10.2337/dc15-0575. View

4.
Gruessner A, Gruessner R . Pancreas Transplantation of US and Non-US Cases from 2005 to 2014 as Reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant Registry (IPTR). Rev Diabet Stud. 2016; 13(1):35-58. PMC: 5291181. DOI: 10.1900/RDS.2016.13.35. View

5.
Sampaio M, Kuo H, Bunnapradist S . Outcomes of simultaneous pancreas-kidney transplantation in type 2 diabetic recipients. Clin J Am Soc Nephrol. 2011; 6(5):1198-206. PMC: 3087789. DOI: 10.2215/CJN.06860810. View